Skip to content

Amplus Corp.

United StatesFDA applicant, unverified

Devices
4

What Amplus Corp. makes

Amplus Corp. manufactures clinical audiometers, including the AMPLAID A308 and AMPLAID 309 models, designed for hearing assessment in medical settings. Their portfolio also includes the AMPLAID 770 admittance meter for tympanometry and impedance testing, as well as the AMPLAID EMG15 for electromyography evaluations.

These devices are classified as Class II under FDA regulations and are supported by 510(k) clearance records. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue4

Newest first, rows 1-4 of 4

  • Amplaid A308 Clinical Audiometer Ref K891988

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Amplaid 309 Clinical Audiometer Ref K880059

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Amplaid 770 Admittance Meter Ref K903066

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Amplaid EMG15 Ref K884071

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Amplus Corp. have in the registry?

The registry currently lists 4 devices for Amplus Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Amplus Corp.'s devices?

Among its 4 most recently registered devices, Amplus Corp. has devices listed in FDA 510(k) (4 devices).

What risk classes do Amplus Corp.'s devices fall under?

Among its 4 most recently registered devices, the classes recorded for Amplus Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Amplus Corp. in the registry?

The most recently registered devices listed for Amplus Corp. include AMPLAID A308 CLINICAL AUDIOMETER, AMPLAID 309 CLINICAL AUDIOMETER, AMPLAID 770 ADMITTANCE METER and AMPLAID EMG15.

Generated automatically from registry data and not verified by a human reviewer.